Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference
Get Alerts INGN Hot Sheet
Join SI Premium – FREE
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19, 2023 at 12:45 p.m. Eastern Time.
A live audio webcast and archived recording of the presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230404006095/en/
Agnes Lee
[email protected]
Source: Inogen, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Messer Acquires Singapore-Based Industrial Gas Platform; Japan Corporate Advisory Institute Advises Sellers
- KT&G announcement: "American investor Capital Research and Management acquires additional 1.04 million shares, increasing stake again to 8.2%"
- Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share